Cargando…
Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma
Metabolic reprogramming is a hallmark of glioma, and sterol O-acyltransferase 1 (SOAT1) is an essential target for metabolic therapy. However, the prognostic value of SOAT1 and its association with immune infiltration has not been fully elucidated. Using RNA-seq and clinical data of glioma patients...
Autores principales: | Guo, Xuyang, Zhou, Shaolong, Yang, Zhuo, Li, Zi-An, Hu, Weihua, Dai, Lirui, Liang, Wulong, Wang, Xinjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133349/ https://www.ncbi.nlm.nih.gov/pubmed/35646697 http://dx.doi.org/10.3389/fonc.2022.896433 |
Ejemplares similares
-
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
por: Dai, Lirui, et al.
Publicado: (2022) -
Cholesterol metabolism and its implication in glioblastoma therapy
por: Guo, Xuyang, et al.
Publicado: (2022) -
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma
por: Dai, Lirui, et al.
Publicado: (2023) -
Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types
por: Dai, Lirui, et al.
Publicado: (2023) -
Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy
por: Tu, Teng, et al.
Publicado: (2023)